Research on C6 glioma cells demonstrated that blocking both CB1 (SR141716 A) and CB2 (SR144528) receptors was necessary to protect cells from the antiproliferative effects of Δ9-THC (Vaccani et al. 2005). Here, CNR1 is linked to central nervous system cancer.